What does palmar erythema indicate in a patient with cirrhosis and how should it be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Palmar Erythema in Cirrhosis

Palmar erythema in cirrhosis is a cutaneous manifestation of chronic liver disease that indicates established cirrhosis and reflects the severity of hepatic dysfunction, but it requires no specific treatment and serves primarily as a clinical marker for underlying disease progression. 1

Clinical Significance and Pathophysiology

Palmar erythema is one of the cardinal physical examination findings in patients with cirrhosis and represents a hormonal and vascular change associated with chronic liver disease. 1, 2, 3

Key clinical points:

  • Palmar erythema appears when frank cirrhosis has developed and is grouped with other stigmata of chronic liver disease including spider nevi, both reflecting the severity of underlying hepatic pathology. 1, 4

  • This finding is described more frequently as a marker for alcoholic etiology of chronic liver disease, though it can occur in cirrhosis of any cause. 5, 4

  • The presence of palmar erythema correlates with disease severity and is part of the spectrum of cutaneous manifestations that result from hormonal changes and vascular alterations in cirrhosis. 2, 3

Evaluation Approach

When palmar erythema is identified, the evaluation should focus on confirming cirrhosis, determining etiology, and assessing for complications rather than treating the skin finding itself.

Initial diagnostic workup should include: 6

  • Comprehensive hepatic function panel: bilirubin, AST, ALT, alkaline phosphatase, albumin, PT/INR, and platelet count 6
  • Complete blood count and renal function tests 6
  • Etiologic testing: hepatitis B panel, hepatitis C antibody with confirmatory RNA when positive, ferritin and transferrin saturation, autoimmune markers if etiology unclear 6

Imaging and non-invasive assessment: 6

  • Abdominal ultrasound as initial imaging modality (65-95% sensitivity for detecting cirrhosis) 6
  • Transient elastography to assess fibrosis stage (cirrhosis typically confirmed at ≥15 kPa) 6
  • Hepatocellular carcinoma screening with ultrasound every 6 months for all patients with cirrhosis 6

Assessment for Complications

The presence of palmar erythema signals established cirrhosis and mandates evaluation for complications: 1

  • Portal hypertension manifestations: ascites, splenomegaly, variceal hemorrhage 1
  • Hepatic encephalopathy 1
  • Hepatorenal syndrome 1
  • Spontaneous bacterial peritonitis in patients with ascites 1, 6

Prognostic scoring should be calculated: 6

  • MELD-Na score (incorporates bilirubin, INR, creatinine, and sodium) 6
  • Child-Pugh score components 6
  • These scores should be reassessed every 6 months 6

Management Strategy

Palmar erythema itself requires no specific treatment. 2, 4 Management focuses entirely on the underlying cirrhosis and its complications.

Primary management priorities:

  • Address the underlying etiology: antiviral therapy for viral hepatitis, alcohol cessation for alcoholic liver disease, weight loss for nonalcoholic fatty liver disease 6, 7
  • Screen for and manage complications: varices, ascites, hepatic encephalopathy, hepatocellular carcinoma 1, 7
  • Optimize nutrition and avoid hepatotoxic medications 7

Upper endoscopy screening: 6

  • Perform for all patients with newly diagnosed cirrhosis unless BOTH criteria are met: platelets >150,000/μL AND liver stiffness <20 kPa by transient elastography 6

Ascites evaluation if present: 1, 6

  • Diagnostic paracentesis must be performed immediately in any hospitalized patient with cirrhosis or new-onset ascites 1, 6
  • Calculate serum-ascites albumin gradient (SAAG) to confirm portal hypertension 6
  • Neutrophil count >250 cells/mm³ confirms spontaneous bacterial peritonitis 6

Critical Clinical Pitfalls

Common mistakes to avoid:

  • Do not assume normal aminotransferases exclude cirrhosis – up to half of cirrhotic patients may have normal ALT/AST values. 6
  • Do not delay paracentesis based on coagulopathy or thrombocytopenia – diagnostic paracentesis is not contraindicated by prolonged PT/INR or low platelets. 6
  • Do not ignore the absence of fever in suspected infection – fever is often absent in cirrhotic patients with sepsis, requiring high clinical suspicion. 8
  • Peripheral stigmata like palmar erythema are seen less routinely now due to earlier diagnosis and better therapy, so their absence does not exclude cirrhosis. 5

Monitoring Schedule

For patients with established cirrhosis indicated by palmar erythema and other stigmata: 6

  • Liver function tests and prognostic scores every 6 months for compensated cirrhosis 6
  • Every 1-3 months for decompensated cirrhosis or active complications 6
  • Hepatocellular carcinoma surveillance with ultrasound every 6 months 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cirrhosis.

The Medical clinics of North America, 2022

Research

Dermatologic disorders and the liver.

Clinics in liver disease, 2011

Research

Caput medusae in alcoholic liver disease.

Nigerian journal of clinical practice, 2011

Guideline

Laboratory Tests for Cirrhosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Liver Disease: Cirrhosis.

FP essentials, 2021

Guideline

Management of Leukopenia in Liver Cirrhosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.